← Back to directory

Luca Boni

Researcher Next ID · RN-040371

Researcher · Biochemistry, Genetics and Molecular Biology

Media Working Group

Portland, Ireland

Accepting doctoral researchersFunding unknown
Works count
505
Citation count
15,230
H-index
59
i10-index
196

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Colorectal Cancer Treatments and Studies
Lung Cancer Treatments and Mutations
Estrogen and related hormone effects
Breast Cancer Treatment Studies
Cancer Treatment and Pharmacology

Publications

  • Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00274-1

  • Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

    The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00637-4

  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30862-9

  • Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

    Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01779

  • Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient–Level Data

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.78.0858

  • FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

    The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00122-9

  • Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

    New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1403108

  • Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

    Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.34.4911

  • Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk196

  • Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

    PubMed · 2003

Current projects

    No projects listed.